Literature DB >> 7180577

Drug-induced neutropenia--a survey for Stockholm 1973-1978.

P Arneborn, J Palmblad.   

Abstract

Hospital records of 256 patients discharged with a diagnosis of agranulocytosis during 1973-78 in the Stockholm County region were reviewed. In 84 cases the neutropenia was probably caused by drugs other than cytostatics, giving an annual incidence of 0.009%. The commonest drugs were sulfonamides, thyreostatics and thenalidine. Metamizole (Dipyrone), previously the commonest cause of drug-induced neutropenia in Sweden, has not been marketed since 1973 and, as a result, only two cases were seen (the drug had been obtained abroad). Comparison of the number of cases of neutropenia with drug sales showed the highest frequency for thenalidine, followed by thyreostatics, penicillamine and sulfonamides, in that order. Only about 35% of the cases had been reported to the authorities. Nine (11%) of the patients died. It is concluded that the pattern of drugs causing neutropenia has changed in Sweden since the studies from the latter half of the 60s and that early detection of this side-effect requires directed and continuous follow-up studies.

Entities:  

Mesh:

Year:  1982        PMID: 7180577     DOI: 10.1111/j.0954-6820.1982.tb03216.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  15 in total

1.  Drug related admissions to medical wards: a population based survey.

Authors:  J Hallas; L F Gram; E Grodum; N Damsbo; K Brøsen; T Haghfelt; B Harvald; J Beck-Nielsen; J Worm; K B Jensen
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

2.  Could Swedish 'yellow cards' be substituted by E-coded summaries?

Authors:  C Jorup-Rönström; M Keisu; B E Wiholm
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

3.  Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.

Authors:  Tyler B Hughes; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2017-02-02       Impact factor: 3.739

Review 4.  Hematological side effects of co-trimoxazole.

Authors:  H Heimpel; A Raghavachar
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 5.  Drug-induced agranulocytosis.

Authors:  H Heimpel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

6.  Agranulocytosis associated with Maloprim.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-07

7.  Amoxycillin induced pancytopenia.

Authors:  A E Irvine; A N Agnew; T C Morris
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

8.  Comparing risk estimates of sulphonamide-induced agranulocytosis from the Swedish Drug Monitoring System and a case-control study.

Authors:  M Keisu; E Ekman; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidence.

Authors:  M Keisu; E Ekman
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  Incidence and risk factors for agranulocytosis in Latin American countries--the Latin Study: a multicenter study.

Authors:  Nelson Hamerschlak; Eliane Maluf; Alexandre Biasi Cavalcanti; Alvaro Avezum Júnior; José Eluf-Neto; Roberto Passeto Falcão; Irene Gyongyvér Heidemarie Lorand-Metze; Daniel Goldenberg; Cézar Leite Santana; Daniela de Oliveira Werneck Rodrigues; Leny Nascimento da Motta Passos; Erika Oliveira de Miranda Coelho; Maria Carolina Tostes Pintão; Hélio Moraes de Souza; José Rafael Borbolla; Ricardo Pasquini
Journal:  Eur J Clin Pharmacol       Date:  2008-06-26       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.